Status:
COMPLETED
A Prospective Registry of Patients With Congenital Penile Anomalies
Lead Sponsor:
Seoul National University Hospital
Conditions:
Concealed Penis
Hypospadias
Eligibility:
MALE
Up to 18 years
Brief Summary
Prospective registry and biobank in pediatric patients with congenital penile anomalies
Detailed Description
According to the U.S. Center for Disease Control and Prevention, in the United States, one in 200 babies is born with congenital penile anomalies. In Korea, there is a rapid increase rate among other ...
Eligibility Criteria
Inclusion
- Those with congenital penile anomalies (e.g. hypospadias, chordee, webbed penis) and receiving penoplasty at the institution.
- Those who understand the registry's content and are signed and dated by the patient (or the patient's legal guardian or representative).
Exclusion
- Those who are unwilling to participate and do not sign the informed consent.
- Unable to read or understand Korean.
Key Trial Info
Start Date :
July 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04755803
Start Date
July 10 2020
End Date
March 30 2023
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea